The signaling axis formed by the chemokine CXCL12 and its receptor CXCR4 plays an important role in B cell development and activation and is finely regulated by a process 
Introduction
The signalling induced by the G protein-coupled receptor Cxcr4 upon binding of its ligand the chemokine Cxcl12 plays an essential role in B cell homeostasis. Indeed, Cxcl12, although known as SDF-1, was originally identified as an early B cell survival factor 1, 2 . Since then numerous studies have reinforced the relevance of this signalling axis for B cell development.
Several works have notably established its central role for the regulation of the germinal centre (GC) reaction and for plasma cell (PC) homing to and persistence within the BM [3] [4] [5] [6] [7] [8] .
However, the role of this axis in the extra-follicular humoral response has never been formally addressed.
Cxcr4/Cxcl12 signalling is tightly regulated by a mechanism called desensitization that relies on the phosphorylation of the C-terminus tail of the receptor and the subsequent recruitment of β-arrestins. This mechanism is absolutely required to uncouple the G-proteins from the receptor and thus for shutting down the Cxcl12-induced signalling. Recruitment of the β-arrestins then leads to receptor internalization through clathrin-coated pits and to its degradation or recycling to the surface 9 . Our group and others showed that this desensitization process is defective in a rare immunodeficiency called the WHIM syndrome (WS) 10, 11 . Most WS patients present mutations in the C-ter tail of CXCR4 thus abrogating the desensitization of the receptor and leading to a gain of function characterized by a hyperactive receptor upon CXCL12 binding 10, 12 . To decipher the cellular and molecular mechanisms underlying the physiopathology of the WS we generated a knock-in mouse model bearing one of the mutations identified in WS patients (mutation at the 1013 position and leading to a 15 amino acid truncation) 13 . These mice referred to as Cxcr4 +/1013 , phenocopied most of the WS features including a gain of function of Cxcr4 upon Cxcl12 stimulation and a severe pan-leukopenia 13 .
Moreover, using this unique model we recently showed that the gain of function of Cxcr4 affects in a B-cell intrinsic manner the T-dependent immune response and recapitulates the vaccination failures reported in WS patients. In addition, we observed an early aberrant accumulation of immature plasmablasts (PBs) in the BM following immunization in absence of Cxcr4 desensitization 7 .
Strikingly, the same (C1013G) mutation of CXCR4 has also been reported in Waldenström's Macroglobulinemia (WM), a rare indolent lymphoplasmacytic B-cell lymphoma characterized by an IgM peak and BM infiltration of malignant B cells with a phenotype going from activated B cells to PCs 14, 15 . This somatic CXCR4 mutation is observed in 20-30%
of WM patients, is always found in conjunction with a MYD88 gain of function mutation (itself presents in 90% of patients) and is associated with poor prognosis, BM involvement and therapy resistance 16, 17 . How these two mutations synergize is still unclear but, together with our recent findings 7 , this raises the question of the impact of Cxcr4 desensitization in the context of MyD88 signalling on B cell and PC biology. We thus took advantage of our unique mouse model to unravel the implication of Cxcr4 desensitization on these processes. Our results demonstrate both in vitro and in vivo that Cxcr4 desensitization is an essential mechanism that dampens MyD88-mediated PC differentiation, maturation and migration.
Importantly, we also report that Cxcr4 desensitization is a regulatory mechanism that controls B cell entry into cycle. Altogether our results demonstrate that Cxcr4 signalling needs to be tightly regulated to limit the extent of the B cell extra-follicular response.
Results

Cxcr4 desensitization limits Myd88-mediated plasma cell differentiation in vitro and in vivo:
To assess how the Cxcr4 gain of function resulting from the defective desensitization of the receptor may impact Myd88-mediated B cell activation we stimulated splenic B cells from WT and Cxcr4 +/1013 mice with the TLR4 and TLR9 ligands, LPS and CpG, in vitro in presence or in absence of Cxcl12. As expected we observed a strong induction of PB differentiation 4 days after LPS and CpG stimulation in the WT conditions ( Figure 1A -B and Figure S1A ). In presence of the gain-of-function mutation of Cxcr4, PB differentiation induced by both TLR ligands was significantly enhanced compared to WT B cells ( Figure   1A -B and Figure S1A ). This increased differentiation translated into increased IgM concentration measured in the supernatant of mutant B cell cultures compared to the WT ones We next determined in vivo whether the gain of function of Cxcr4 was impacting the TLRmediated Type 1 T-independent B cell immune response. WT and Cxcr4 +/1013 mice were immunized i.p. with NP-LPS and the splenic immune response was evaluated at day 3 and 6 post injection ( Figure 1C ). The immunization was not correcting the B cell lymphopenia observed in the spleen of Cxcr4 +/1013 mice 13 ( Figure 1D ). This was mostly due to the reduced frequency and number of follicular B cells in mutant mice ( Figure S1D ). As previously reported, the frequency of marginal zone (MZ) B cells was increased and their number was normal in Cxcr4 +/1013 mice compared to WT mice 13 and this was not altered by NP-LPS immunisation ( Figure S1D ).
We further analysed splenic plasmablast (PB) generation and observed a significant increase of the frequency of PBs from day 3 that was still prominent at day 6 in Cxcr4 Analysis of splenic PBs by immunohistofluorescence revealed an increased detection in sections and also a more diffuse distribution in the red pulp in Cxcr4 +/1013 spleens compared to WT spleens ( Figure 1H ).
Altogether, these results suggest that Cxcr4 desensitization is an important regulator of PC differentiation.
Cxcr4 desensitization limits the entry of LPS-stimulated B cells into cycle:
We addressed the cellular mechanism underlying this enhanced PB generation in absence of Cxcr4 desensitization in vitro. We first showed that the gain of function of Cxcr4 was not affecting B cell and PB survival by performing Annexin V/DAPI and active Caspase 3 staining on LPS-mediated in vitro differentiation of WT and mutant splenocytes at day 2 and 4 ( Figure S2A ). This was supported by the analysis of the expression of key apoptosis regulators in PBs from WT and Cxcr4 +/1013 mice at day 4 after LPS stimulation ( Figure S2B ).
We then evaluated whether proliferation may be impacted by the gain of function of Cxcr4.
Splenic B cells were loaded with CTV and stimulated with LPS in absence or presence of Cxcl12. The CTV dilution was assessed from day 2 and up to day 4. Strikingly, we observed at day 2 that more mutant B cells had proliferated compared to WT B cells (Figure 2A -B).
However, this difference was not detected anymore from day 3 of culture ( Figure 2B ). The addition of Cxcl12 to the culture did not significantly increase B cell proliferation compared to the LPS-only condition but we still observed more proliferation at day 2 in B cells mutant for Cxcr4 ( Figure S2C ). Cxcl12 on its own was only inducing minimal B cell proliferation however, mutant B cells were cycling more than their WT counterparts ( Figure S1C and S2C). We also measured CTV dilution in newly generated PBs and did not observe difference in the proliferation of WT and mutant PBs at any time point analysed in presence or in absence of Cxcl12 ( Figure 2C -D and Figure S2D ). Of note, in presence of Cxcl12 only we observed more proliferation for the mutant PBs compared to the WT ones at day 2 but this difference was not detectable anymore the following days ( Figure S2D ). These results brought us to consider whether it was not the proliferation of B cells that was affected but rather their entry in cycle. We thus, measured the frequency of B cells in G0, G1, S and G2-M phases following LPS stimulation. From day 1 and up to day 3 we observed a significant increase in the percentage of B cells in cycle (G1, S and G2-M phases) in Cxcr4 +/1013 cultures compared to WT ones ( Figure 2E -F and data not shown for day 1). The addition of Cxcl12 to the stimulation medium did not significantly increase the cycling of B cells compared to the condition with LPS alone ( Figure S2E ). As expected, most PBs were cycling 18 and no difference was observed between our two experimental groups ( Figure 2F , right panel).
Moreover, a transcriptomic analysis confirmed that mutant splenic B cells 6 days after LPS injection present a characteristic cycling signature that is not observed in WT B cells ( Figure   S2F ). Previous reports demonstrated that B cell differentiation into PB necessitates at least 3 rounds of cell division 19 . We thus assessed whether this enhanced cycling of B cells may account for an accelerated differentiation. We cultured WT x Blimp1-GFP and Cxcr4 +/1013 x Blimp-1 GFP B cells with LPS and assessed the kinetic of appearance of GFP by videomicroscopy. As shown in Figure 2G , some GFP+ cells were already detectable in desensitization is an essential regulator of splenic B cell entry into cycle and this enhanced cycling seems to translate into exacerbated PB differentiation.
Cxcr4 desensitization controls follicular and MZ B cell differentiation into PB via distinct mechanisms:
As shown previously 13 , Cxcr4 +/1013 mice have reduced number of follicular B cells but normal number of MZ B cells. We thus wondered if the difference observed in terms of MyD88-mediated PB differentiation in absence of Cxcr4 desensitization could be explained by the different representation of these two subsets between WT and mutant mice. We thus sorted follicular and MZ B cells and differentiated them in vitro with LPS. We observed that both subsets were generating more PBs when they were bearing the Cxcr4 gain of function mutation ( Figure 3A ). The analysis of the cell cycle at day 2 post-LPS stimulation showed that follicular B cells bearing the Cxcr4 gain of function mutation were more in cycle than the WT ones ( Figure 3B ) with the frequency of cycling cells increasing from day 1 to day 3
( Figure 3B and Figure S3A (for day1)). As expected, after LPS stimulation MZ B cells were more in cycle than follicular B cells ( Figure 3D -E) 20 . However, there was no significant difference in terms of cycle between mutant and WT MZ B cells at all time points analysed ( Figure 3D -E and Figure S3B ). To support these findings, we fed WT and Cxcr4 +/1013 mice with EdU for 6 days and analysed EdU incorporation at day 6 and progressive EdU loss during a chase in splenic follicular and MZ B cells in vivo ( Figure 3F ). As shown in Figure   3G , 
Cxcr4 desensitization limits plasmablasts accumulation within the bone marrow:
We previously reported that during a T-dependent response the desensitization of Cxcr4 was essential to limit the apparition of aberrant PBs within the BM presumably generated independently of the germinal centre response 7 . We thus investigated if such was the case in a humoral response that was independent of T cell help and not leading to GC formation. WT
and Cxcr4 +/1013 mice crossed to the Blimp1 GFP reporter strain were immunized i.p. with NP-LPS and their BM was analysed after 3 and 6 days ( Figure 4A ). As previously reported the BM cellularity was equivalent between WT and Cxcr4 +/1013 mice 13 ( Figure 4B ). We observed an increased detection of total IgM + ASCs from day 3 and of NP-specific IgM + ASCs from Figure   4H , Cxcr4 +/1013 mutant PBs had an intrinsic homing advantage to the BM compared to WT PBs at all time points considered. On the contrary, fewer mutant PBs and more WT PBs were observed in the spleen of the recipient mice ( Figure 4H ). This experiment suggests that mutant PBs have an intrinsic advantage in terms of BM homing. In summary, our data support that Cxcr4 desensitization is a control mechanism regulating the homing to the BM of PBs generated after LPS challenge or spontaneously in old mice experiencing inflammaging. We next assessed the fate of these cells in terms of persistence and proliferation. We observed that transferred WT and Cxcr4 +/1013 BM PB/PC lose the cell trace dyes equivalently ( Figure   5E and S5A) suggesting that they proliferate at the same rate. Moreover, we assessed BM PB and PC fate during an EdU pulse chase experiment (see Figure 3F for experimental design).
At the end of the EdU labelling (6 days post immunization with NP-LPS) most of the BM PBs (CD138 + B220 + ) were EdU high suggesting that they had incorporated the dye recently ( Figure 5F ). In line with their proliferative nature more than 70% of BM PBs were EdU + at day 6 at the end of the labelling ( Figure 5G , top). As expected considering their quiescent nature, less than 50% of BM PCs were EdU + after 6 days of labelling ( Figure 5G , bottom). At the end of the labelling period (day 6) the frequency and number of EdU + PBs and PCs were higher in Cxcr4 +/1013 mice compared to WT ones ( Figure 5F -G). This may reflect the enhanced generation of PBs in the spleen and their enhanced migration to the BM. When we followed the EdU loss during the chase we observed that both WT and mutant PBs and PCs lose it at the same rate ( Figure 5G , left panels). This was also true for splenic PBs ( Figure   S5B ). Figure 5G ) hence supporting that mutant PBs may indeed give rise to PCs between day 6 and 12. Accordingly, we observed that the EdU MFI for mutant PCs was higher at day 8 than at day 6 ( Figure 5F and H). As no more EdU is given at this time, this suggests that EdU than their WT counterparts ( Figure 6D ). The frequency of Cxcr3 + PBs was also increased in the spleen of mutant mice compared to WT ones ( Figure 6D ). These differences were even more marked when we analysed PBs and PCs from the BM of WT and mutant mice ( Figure 6E ). In addition, mutant BM PBs express more Vla4 and Lfa1 at their surface than WT PBs.
This was also observed albeit less marked for mutant and WT BM PCs ( Figure 6E ). Thus, in absence of Cxcr4 desensitization, splenic PBs display an enhanced homing capacity towards the BM that is not only due to the gain of function of Cxcr4 but to a more global change in the migratory code of these cells controlled by the exacerbated Cxcr4/Cxcl12 signalling.
Moreover, the increased expression of several adhesion molecules observed in mutant BM PBs may explain their enhanced maturation and persistence within the BM environment.
Discussion
Cxcr4 is a well-known regulator of the immune system. 
Material and Methods
Mice:
Cxcr4 +/1013 mice (C57Bl/6J background) were generated as previously described 13 . Blimp 
Immunization and Edu feeding:
Mice were immunized intra-peritoneally with 25 µg of 4-hydroxy-3-nitrophenylaceyllipopolysaccharide (NP-LPS) (Biosearch Technologies). Blood, Spleen and BM were harvested and analysed 3 and 6 days after challenge. For EdU pulse-chase assays, mice were immunised with 25 µg NP-LPS and injected intra-peritoneally with 1 mg Edu (SigmaAldrich) and maintained on drinking water containing 500 µg/ml Edu and 1% glucose during 6 days. The Edu labelling was followed by a chase period of 2, 6, 12 and 33 days 
Single cell suspension:
Isolation of organs was performed upon euthanasia by inhalation of CO2. The BM was harvested from femurs, tibias and hip by centrifugation in culture medium (RPMI with 10%
decomplemented foetal calf serum and penicillin 100Units/mL/streptomycin100µg/mL (all from Gibco)). Spleens were gently mashed on a 70µm nylon mesh and recovered cells were then suspended in culture medium. Red blood cells from spleen and BM single cell suspension were lysed for 5 min in 1 mL ammonium-chloride-potassium buffer. Harvested cells from tissues were either directly immunophenotyped or used for in vitro functional assays.
Adoptive transfer experiments:
Splenocytes from both WT x Blimp1 GFP/+ and Cxcr4 +/1013 x Blimp1 GFP/+ mice were stimulated 
In vitro functional assays:
For PB differentiation, B cells were isolated from total splenocytes using naïve mouse B-cell isolation kit (Miltenyi Biotec) according to the manufacturer's instructions. Total splenocytes or isolated B cells were cultured using RPMI (with 10% decomplemented foetal calf serum, 1% penicillin 100Units/mL/streptomycin100µg/mL (Gibco), 50µM β-mercaptoethanol (PAN biotech), 1mM sodium pyruvate (Gibco) and Minimum essential medium non-essential amino and then labelled with an anti-Ki-67 antibody (clone B56, mouse IgG1; BD) and DAPI was added before flow cytometry analysis.
Flow cytometry:
Single cell suspensions were stained as previously described (biajoux et al 2016), using the 
Immunofluorescence:
Spleens were fixed for 4 hours in PBS-paraformaldehyde (PFA) 4% and were subsequently washed in PBS and left over night in PBS with 20% sucrose. Spleens were then embedded in OCT (TissueTek) and stocked at -80°C before sectioning. Cryosections (7 µm) were permeabilized with PBS triton X100 0.5% for 15 min, washed twice with PBS and blocked with PBS BSA 5% for 1 hour. Sections were stained with primary Abs (rabbit anti-mouse laminin (Sigma Aldrich), Alexa fluor 594 Goat anti-mouse IgM (Thermofisher)) for 1 hour at room temperature (RT). Sections were washed twice with PBS and incubated with the appropriate secondary Ab (Alexa fluor 488 goat anti-Rabbit (Thermofisher)) and Hoechst 33342 for 1 h at RT. Mounting was done using Vectashield medium (Vector Laboratories).
Slides were scanned using a NanoZoomer Digital Pathology system using X40 objective lense with numerical aperture 0.75 (Hamamatsu Photonic). Bone marrow embedding, sectioning and staining were performed as described 38 . Briefly, freshly dissected bones were fixed in PBS-PFA 4% overnight followed by one-week decalcification in EDTA (0.5M) at pH 7.4. Bones were then incubated in PBS 20% sucrose and 2% polyvinylpyrrolidone (PVP) at 4°C overnight. The embedding was performed using PBS with 20% sucrose, 2% PVP and 8%
gelatin. Bones were sectioned (30 µm) using a cryostat. Sections were rehydrated in PBS 1X, incubated 20 min at RT in PBS with 0.3% triton X-100, saturated in blocking solution (PBS-BSA 5%) for 1 hour and finally incubated with primary Abs: rabbit anti-mouse laminin (Sigma), Alexa fluor 594 Goat anti-mouse IgM (Thermofisher) for 1 hour at RT. After washing, sections were incubated with the appropriate secondary Abs: Alexa fluor 488 goat anti-Rabbit (Thermofisher) for 1h at RT with Hoechst 33342 for nuclear staining. Mounting was done using Permafluor mounting medium (Thermofisher). Images were acquired using TCS SP8 confocal microscope and processed with Fiji.
ELISA and ELISpot:
Sera were harvested by tail bleed or by cardiac puncture after euthanasia and IgM or anti-NP IgM titers were determined by ELISA. Sera were incubated 2 h at 37°C on wells pre-coated with AEC (Sigma-Aldrich). The reaction was stopped with water and analyzed using an AID ispot Reader (Autoimmun Diagnostika GMBH).
Time lapse imaging:
B cells were isolated as previously described (see section in vitro assays) and stimulated with LPS, IL4 and IL5 at the indicated concentrations. Cells were either imaged using a Biostation NIKON in a 37°C, 5% Co2 supplemented chamber at a concentration of 10 4 /mL or using the Incucyte® S3 at a concentration of 10 4 cell per well. Cells were imaged for phase-contrast and GFP fluorescence each 15 or 30 minutes. Images and movies where analysed with the Incucyte S3 program, the biostation IM programme and Fiji.
Multiplex qPCR
Multiplex qPCR analysis was performed using the Biomark system. Table 2 ). Targeted cDNA pre-amplification was performed during 20 cycles and the pre-amplified product was diluted 1:5 in TE buffer before processing with Dynamic
Array protocol according to the manufacturer's instructions (Fluidigm). Cells expressing
Gapdh, Actb and control genes (Prdm1, Irf4 and Xpb1 for plasma cells and Pax5 for B cells)
and not negative control (CD3e) were considered for further analysis. Mean expression of Actb and Gapdh gene was used for normalization. Heat maps were generated with ( http://www.heatmapper.ca) using the Z scores and PCA with Past 3.X software using the variance-covariance test.
qRT-PCR
Total cellular RNA was extracted from samples using the RNeasy Plus Mini kit (Qiagen) and was quantified using NanoDrop technology (Thermo Scientific, Wilmington, DE). RNA was 
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